A new treatment for prostate cancer developed and trialled in London has been licensed for use.
Enzalutamide was developed by researchers at the Royal Marsden and University College London hospitals.
The one a day pill checks the spread of the cancer.
Reseachers say the most exciting aspect of this new drug is that is has very few side effects- unlike many cancer treatements.
More top news
Londoners who have received new electronic gadgets for Christmas are being advised to take simple steps to protect them from thieves.
The Boxing Day sales got off to a flying start with shops reporting a surge in business during the first hour of trading.
Bus strikes are planned for Monday 29 December and Monday 5 January.